Episode summary
Warner Bros Reopens Talks as Paramount Signals Higher Bid | Bloomberg Intelligence
Bloomberg Intelligence
· · Hosts: Paul Sweeney, Scarlet Fu · Guests: Stephen Flynn, Mandeep Singh, Sam Fazeli, Jeffrey Langbaum
Summary
Warner Bros. Discovery has reopened negotiations with Paramount Skydance after Paramount signaled it could increase its offer, even though it had not formally raised the bid. The host and Stephen Flynn focused on the deal’s complexity: Paramount’s proposal includes taking on Warner Bros.’ break fees and bridge loan support, but the combined company would still carry about $85 billion of debt. Flynn argued that the deal could only look manageable if rating agencies give substantial credit for projected $6 billion of cost synergies and if the $54 billion financing stack sits ahead of the rest of the debt.
Mandeep Singh said Anthropic’s Pentagon contract talks are being slowed by the company’s desire for stronger guardrails around what Claude can do for government work. He framed that as part of a broader competition among AI vendors for defense use cases, and said Anthropic and OpenAI could both go public this year.
Sam Fazeli said Moderna and Merck’s melanoma program faces three key risks despite encouraging phase 2 data, while FDA uncertainty is making biotech regulation harder to predict. Jeffrey Langbaum said office demand has not broken yet despite AI fears, while senior housing remains his favorite REIT theme because supply is constrained and demand is durable.
Key takeaways
- Stephen Flynn said a Paramount-Warner Bros. combination would leave roughly $85 billion of debt, making leverage the central credit issue.
- Flynn argued the deal could only approach investment-grade treatment if rating agencies give credit for about $6 billion of synergies and senior financing protections.
- Mandeep Singh said Anthropic’s Pentagon talks are being held up by extra guardrails on Claude, unlike some rivals that are pursuing government work without the same emphasis.
- Sam Fazeli said Moderna and Merck’s melanoma readout has real upside, but phase 2 interpretation, healthier phase 3 patients, and COVID-shot interactions could all distort the data.
- Jeffrey Langbaum said office leasing is still strong in New York and San Francisco, while senior housing offers the clearest demand-supply imbalance in REITs.
Notable quotes
“Paramount actually came out. They reiterated a $30 per share cash offer for the entire Warner Brothers Discovery”
“Warner Brothers Discovery would have about $85 billion of total debt pro for this deal”
“the company Enthropic has talked about their AI constitution or in other words putting guardrails around the kind of surveillance activities they want the LLM to do”
“leasing velocity has been at the highest level since before the pandemic in markets like New York and San Francisco”
How the episode opens
Bloomberg Audio Studios, podcasts, radio, news. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. — Listen on demand wherever you get your podcast or watch us live on YouTube.
It is Tuesday, but there's still a lot of M& Tuesday. — Yep. Merger Tuesday. Um although this one's been like in the works for so long now. Warner Brothers, Paramount, Netflix. Looks like Warner Brothers is now open to a Paramount bid. A little bit more open than it was before. Um it is reopening talks with Paramount as Paramount signals a higher bid but has not actually raised.
I'm glad you reported it correctly because they haven't raised their bid. They're saying they said, you know, we could. So I guess that's good enough for them to reopen discussion. Steven Flynn is our senior credit analyst on this developing story. So Stephen, how are you looking at this development?
Yeah, so you think back a couple of weeks ago on February 10th, um Paramount actually came out. They reiterated a $30 per share cash offer for the entire Warner Brothers Discovery, but they did add in a few other things. Number one, they said that they would pay the $2.8 billion termination fee, that Warner Brothers would owe Netflix for breaking that deal.
uh they said that they'd help with the uh $15 billion of U bridge loan uh that Warner Brothers has outstanding from a bond tender deal that they did uh mid last year. Uh they'd also fully reimburse uh Warner Brothers Discovery for a potential $ 1.5 billion fee that Warner Brothers could owe certain bond holders if they do not do a debt exchange by the end of this year.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- entertainment mergers
- ai tool government contracts
- biotech clinical trials
- office real estate demand
- credit outlook
Companies and tickers mentioned
- NFLX
- MRNA
- MRK
- Warner Bros. Discovery
- Paramount Skydance Corp.
- Netflix Inc.
- Anthropic PBC
- Moderna
- Merck & Co., Inc.
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Intelligence
-
Instant Reaction: Nvidia CEO Jensen Huang Ousted by Nvidia Board | Bloomberg Intelligence -
Nvidia’s Huang Ousted by Board in Move That Roils AI Economy | Bloomberg Intelligence -
CoreWeave Shares Soar After AI Computing Firm Eases Debt Fears | Bloomberg Intelligence -
Anthropic Targets $1.4 Trillion Valuation in Blockbuster IPO | Bloomberg Intelligence -
Nvidia Probe Into CEO Affair Raises Thorny Questions for AI | Bloomberg Intelligence -
Election 'Blue Wave' & Your Wallet; Navigating AI-Driven Market Volatility | Bloomberg Intelligence
Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
